Alembic Pharmaceuticals 대차 대조표 상태
재무 상태 기준 확인 6/6
Alembic Pharmaceuticals 의 총 주주 지분은 ₹48.9B 이고 총 부채는 ₹9.9B, 이는 부채 대 자기자본 비율을 20.4% 로 가져옵니다. 총자산과 총부채는 각각 ₹72.3B 및 ₹23.4B 입니다. Alembic Pharmaceuticals 의 EBIT는 ₹7.2B 이며 이자보상배율은 12.9 입니다. ₹1.3B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
20.4%
부채 비율
₹9.95b
부채
| 이자 보상 비율 | 12.9x |
| 현금 | ₹1.29b |
| 주식 | ₹48.88b |
| 총 부채 | ₹23.43b |
| 총 자산 | ₹72.30b |
최근 재무 상태 업데이트
Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?
Sep 03
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly
Jun 03Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?
Jan 05Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly
Sep 27Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly
Jun 09Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?
Feb 22Recent updates
Earnings Miss: Alembic Pharmaceuticals Limited Missed EPS By 5.6% And Analysts Are Revising Their Forecasts
Nov 10Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price
Sep 25Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?
Sep 03Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 13Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher
Jul 20Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly
Jun 03Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?
May 11Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 08Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%
Jan 21Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?
Jan 05Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly
Sep 27Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly
Jun 09A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)
Apr 13Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?
Feb 22Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate
Jan 04We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now
Nov 05Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden
Aug 10Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)
Jul 20재무 상태 분석
단기부채: APLLTD 의 단기 자산 ( ₹37.6B )이 단기 부채( ₹21.7B ).
장기 부채: APLLTD 의 단기 자산( ₹37.6B )이 장기 부채( ₹1.7B ).
부채 대 자본 내역 및 분석
부채 수준: APLLTD 의 순부채 대 자기자본 비율( 17.7% )은 satisfactory로 간주됩니다.
부채 감소: APLLTD 의 부채 대 자기자본 비율은 지난 5년간 51.8% 에서 20.4% 로 감소했습니다.
부채 범위: APLLTD 의 부채는 영업 현금 흐름 ( 41.1% )에 의해 잘 충당되었습니다.
이자 보장: APLLTD 의 부채에 대한 이자 지급은 EBIT( 12.9 x 적용 범위)로 잘 충당됩니다.